Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,150 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $263.24 | 8 | $0 (2021) |
| Medtronic Vascular, Inc. | $149.92 | 1 | $0 (2018) |
| PFIZER INC. | $141.04 | 5 | $0 (2023) |
| Haemonetics Corporation | $139.58 | 2 | $0 (2019) |
| Penumbra, Inc. | $119.47 | 1 | $0 (2024) |
| Allergan, Inc. | $118.43 | 2 | $0 (2020) |
| AbbVie Inc. | $79.21 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $44.42 | 2 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $26.83 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $25.41 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $190.72 | 4 | Penumbra, Inc. ($119.47) |
| 2023 | $16.83 | 1 | PFIZER INC. ($16.83) |
| 2022 | $16.49 | 1 | PFIZER INC. ($16.49) |
| 2021 | $98.25 | 5 | AbbVie Inc. ($79.21) |
| 2020 | $17.43 | 1 | Allergan, Inc. ($17.43) |
| 2019 | $306.52 | 9 | Janssen Pharmaceuticals, Inc ($183.48) |
| 2018 | $295.16 | 6 | Medtronic Vascular, Inc. ($149.92) |
| 2017 | $208.72 | 4 | PFIZER INC. ($107.72) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Rare Disease | ||||||
| 08/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: Cardiology | ||||||
| 05/28/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $119.47 | General |
| Category: Peripheral Intervention | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Rare Disease | ||||||
| 08/23/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/02/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/28/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/05/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/17/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2019 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ANTIBIOTIC | ||||||
| 08/15/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 07/15/2019 | Haemonetics Corporation | TEG (Device) | Food and Beverage | In-kind items and services | $66.99 | General |
| Category: Devices | ||||||
| 07/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $122.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Metabolism & Primary Care | ||||||
| 04/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/26/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Cardiovascular | ||||||
| 02/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/05/2018 | Medtronic Vascular, Inc. | Endurant (Device) | Food and Beverage | In-kind items and services | $149.92 | General |
| Category: Aortic Stent Grafts | ||||||
| 08/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.93 | General |
| Category: Cardiovascular | ||||||
| 05/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 503 | 512 | $438,111 | $49,039 |
| 2022 | 5 | 499 | 517 | $402,677 | $45,280 |
| 2021 | 5 | 589 | 599 | $386,181 | $65,849 |
| 2020 | 5 | 764 | 785 | $419,480 | $88,259 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 199 | 202 | $237,374 | $26,968 | 11.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 142 | 145 | $117,442 | $12,986 | 11.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 46 | 46 | $70,116 | $7,536 | 10.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 18 | 18 | $7,222 | $940.89 | 13.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 98 | 101 | $5,957 | $607.71 | 10.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 215 | 223 | $275,332 | $31,086 | 11.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 82 | 84 | $59,961 | $7,437 | 12.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 24 | $44,423 | $4,179 | 9.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 31 | 31 | $13,736 | $1,612 | 11.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 147 | 155 | $9,225 | $965.36 | 10.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 358 | 365 | $277,691 | $46,755 | 16.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 94 | 96 | $56,408 | $8,732 | 15.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 43 | 43 | $28,970 | $7,319 | 25.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 52 | 52 | $19,960 | $2,774 | 13.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 42 | 43 | $3,152 | $268.96 | 8.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 491 | 508 | $314,184 | $64,943 | 20.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 60 | 61 | $39,587 | $10,402 | 26.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 113 | 113 | $46,683 | $9,596 | 20.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 65 | 66 | $16,470 | $3,076 | 18.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 35 | 37 | $2,556 | $242.22 | 9.5% |
About Dr. Eric Woolley, M.D
Dr. Eric Woolley, M.D is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043231749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Woolley, M.D has received a total of $1,150 in payments from pharmaceutical and medical device companies, with $190.72 received in 2024. These payments were reported across 31 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,150).
As a Medicare-enrolled provider, Woolley has provided services to 2,355 Medicare beneficiaries, totaling 2,413 services with total Medicare billing of $248,426. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 07/21/2006
- Last Updated 12/01/2011
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043231749
Products in Payments
- XARELTO (Drug) $263.24
- DALVANCE (Drug) $197.64
- ELIQUIS (Drug) $166.45
- Endurant (Device) $149.92
- TEG (Device) $139.58
- Indigo System (Device) $119.47
- ANDEXXA (Biological) $58.83
- Assure WCD (Device) $26.83
- NUZYRA (Drug) $14.28
- Activase (Biological) $13.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507